LEWIS JONATHAN 4
4 · ZIOPHARM ONCOLOGY INC · Filed Jan 3, 2013
Insider Transaction Report
Form 4
LEWIS JONATHAN
DirectorCEO
Transactions
- Tax Payment
Common Stock
2012-12-31$4.21/sh−14,715$61,950→ 546,251 total - Award
Employee Stock Option (right to buy)
2012-12-31+300,000→ 300,000 totalExercise: $4.16Exp: 2022-12-31→ Common Stock (300,000 underlying) - Tax Payment
Common Stock
2012-12-31$4.16/sh−21,475$89,336→ 524,776 total
Footnotes (2)
- [F1]Disposition represents shares withheld to satisfy withholding tax obligations upon the vesting of a restricted stock grant.
- [F2]100,000 shares vest on 12/31/2013; and 100,000 shares vest on each of 12/31/2014 and 12/31/2015.